Finance

Beta
Lists
8CC:FRA
Cocrystal Pharma Inc
€0.84
+0.60%
(+0.0050) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8CC...
Open
€0.84
High
€0.84
Low
€0.84
Mkt. cap
13.72M
Avg. vol.
3.00
Volume
0.00
52-wk high
€2.80
52-wk low
€0.70
No. of employees
10
Open
€0.84
High
€0.84
Low
€0.84
Mkt. cap
13.72M
Avg. vol.
3.00
Volume
0.00
52-wk high
€2.80
52-wk low
€0.70
No. of employees
10
News stories
From sources across the web
About Cocrystal Pharma Inc
CEO-
Employees10
Founded2006
HeadquartersBothell, Washington, United States
SectorPharmaceutical industry
Websitecocrystalpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
225.00K
Cost of goods sold
1.12M
954.00K
1.62M
1.37M
Cost of revenue
1.12M
954.00K
1.62M
1.37M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
986.00K
1.14M
862.00K
1.21M
Operating expense
986.00K
1.14M
862.00K
1.21M
Total operating expenses
2.11M
2.09M
2.48M
2.58M
Operating income
-2.11M
-2.09M
-2.48M
-2.36M
Other non operating income
-
-
-
-
EBT including unusual items
-2.06M
-2.05M
-2.43M
-2.30M
EBT excluding unusual items
-2.06M
-2.05M
-2.43M
-2.30M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.06M
-2.05M
-2.43M
-2.30M
Net profit margin
-
-
-
-1,021.78%
Earnings per share
-0.20
-0.19
-0.17
-0.17
Interest and investment income
28.00K
22.00K
47.00K
22.00K
Interest expense
-
-
-
-
Net interest expenses
28.00K
22.00K
47.00K
22.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.09M
-2.08M
-2.47M
-2.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer